CV Sciences Statistics
Total Valuation
CV Sciences has a market cap or net worth of 5.96 million. The enterprise value is 7.68 million.
| Market Cap | 5.96M |
| Enterprise Value | 7.68M |
Important Dates
The last earnings date was Thursday, March 26, 2026.
| Earnings Date | Mar 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CV Sciences has 193.99 million shares outstanding. The number of shares has increased by 4.94% in one year.
| Current Share Class | 193.99M |
| Shares Outstanding | 193.99M |
| Shares Change (YoY) | +4.94% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 8.19% |
| Owned by Institutions (%) | n/a |
| Float | 178.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.43 |
| PB Ratio | 4.06 |
| P/TBV Ratio | 15.81 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -8.02 |
| EV / Sales | 0.56 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -14.88 |
Financial Position
The company has a current ratio of 1.03, with a Debt / Equity ratio of 1.36.
| Current Ratio | 1.03 |
| Quick Ratio | 0.14 |
| Debt / Equity | 1.36 |
| Debt / EBITDA | n/a |
| Debt / FCF | -3.87 |
| Interest Coverage | -0.91 |
Financial Efficiency
Return on equity (ROE) is -58.72% and return on invested capital (ROIC) is -16.47%.
| Return on Equity (ROE) | -58.72% |
| Return on Assets (ROA) | -3.95% |
| Return on Invested Capital (ROIC) | -16.47% |
| Return on Capital Employed (ROCE) | -23.96% |
| Weighted Average Cost of Capital (WACC) | 10.43% |
| Revenue Per Employee | 320,674 |
| Profits Per Employee | -22,279 |
| Employee Count | 44 |
| Asset Turnover | 1.85 |
| Inventory Turnover | 1.57 |
Taxes
In the past 12 months, CV Sciences has paid 9,000 in taxes.
| Income Tax | 9,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +2.81% in the last 52 weeks. The beta is 0.51, so CV Sciences's price volatility has been lower than the market average.
| Beta (5Y) | 0.51 |
| 52-Week Price Change | +2.81% |
| 50-Day Moving Average | 0.05 |
| 200-Day Moving Average | 0.04 |
| Relative Strength Index (RSI) | 40.20 |
| Average Volume (20 Days) | 879,457 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.06 |
Income Statement
In the last 12 months, CV Sciences had revenue of 13.79 million and -958,000 in losses. Loss per share was -0.01.
| Revenue | 13.79M |
| Gross Profit | 6.75M |
| Operating Income | -470,000 |
| Pretax Income | -949,000 |
| Net Income | -958,000 |
| EBITDA | -278,000 |
| EBIT | -470,000 |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 278,000 in cash and 2.00 million in debt, with a net cash position of -1.72 million or -0.01 per share.
| Cash & Cash Equivalents | 278,000 |
| Total Debt | 2.00M |
| Net Cash | -1.72M |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | 1.47M |
| Book Value Per Share | 0.01 |
| Working Capital | 133,000 |
Cash Flow
In the last 12 months, operating cash flow was -407,000 and capital expenditures -109,000, giving a free cash flow of -516,000.
| Operating Cash Flow | -407,000 |
| Capital Expenditures | -109,000 |
| Depreciation & Amortization | 192,000 |
| Net Borrowing | 427,000 |
| Free Cash Flow | -516,000 |
| FCF Per Share | -0.00 |
Margins
Gross margin is 48.97%, with operating and profit margins of -3.41% and -6.95%.
| Gross Margin | 48.97% |
| Operating Margin | -3.41% |
| Pretax Margin | -6.88% |
| Profit Margin | -6.95% |
| EBITDA Margin | -2.02% |
| EBIT Margin | -3.41% |
| FCF Margin | n/a |
Dividends & Yields
CV Sciences does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.94% |
| Shareholder Yield | -4.94% |
| Earnings Yield | -16.07% |
| FCF Yield | -8.66% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CV Sciences has an Altman Z-Score of -15.2 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -15.2 |
| Piotroski F-Score | 4 |